Treat chronic wounds with a haemoglobin-based spray

By Mölnlycke

Mölnlycke’s Granulox, a topical haemoglobin-based spray for the treatment of chronic wounds, improves patient outcomes by oxygenating the base of their wounds and has been shown to result in shorter healing time, reduced pain scores and total cost savings for healthcare providers compared with the standard of care. Diabetic foot specialist Rosalyn Thomas explains how it has contributed to her practice.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.